N
Novavax
Gaithersburg, United States
Founded 1987 NASDAQ: NVAX
About
Recombinant nanoparticle vaccine technology for infectious diseases
Company Details
- Type
- public
- Employees
- 1500+
- Funding
- Public
Key Products
- Nuvaxovid
- Matrix-M Adjuvant